Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients

    A Kruchen, T Stahl, F Gieseke, T M C Binder, Z Özcan in Bone Marrow Transplantation (2015)

  2. No Access

    Article

    Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation

    To investigate the relationship between clinical response and modification of BK viremia, we assessed retrospectively 32 cases of hemorrhagic cystitis (HC) after allogeneic hematopoietic SCT that were treated ...

    S Cesaro, M Pillon, G Tridello, M Aljurf, R Martino in Bone Marrow Transplantation (2013)

  3. No Access

    Article

    Allo-SCT using BU, CY and melphalan for children with AML in second CR

    Based on the results from the AML-BFM 98 trial, hematopoietic SCT (HSCT) is recommended for children with AML in second CR only. Here, we retrospectively analyze interphase data of children who underwent HSCT ...

    R Beier, M H Albert, P Bader, A Borkhardt, U Creutzig in Bone Marrow Transplantation (2013)

  4. No Access

    Article

    Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience

    We report the long-term follow-up of children transplanted with Treosulfan (TREO)-based conditioning in Germany and Austria. Nine centres reported a total of 109 transplantations. Patients were stratified acco...

    R Beier, A Schulz, M Hönig, M Eyrich, P-G Schlegel, W Holter in Bone Marrow Transplantation (2013)

  5. No Access

    Article

    Pitfalls of “hyper”-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature

    Here, we report on a male infant with low serum IgG, IgA and IgM levels who suffered from Pneumocystis jirovecii and cytomegalovirus (CMV) pneumonia. The patient was tested to be HIV-negative. Absolute and relati...

    A. Heinold, B. Hanebeck, V. Daniel, J. Heyder, T. H. Tran, B. Döhler, J. Greil in Infection (2010)

  6. No Access

    Article

    Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT

    MLL/AF4 and AML/MTG8 represent two leukemic fusion genes, which are most frequently found in infant acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), respectively. We examined the influence of

    A Gessner, M Thomas, P Garrido Castro, L Büchler, A Scholz, T H Brümmendorf in Leukemia (2010)

  7. No Access

    Article

    Successful SCT for Nijmegen breakage syndrome

    Nijmegen breakage syndrome (NBS) is characterized by chromosomal instability, radiation hypersensitivity, characteristic facial appearance, immunodeficiency and strong predisposition to lymphoid malignancy. Tr...

    M H Albert, A R Gennery, J Greil, C M Cale, K Kalwak in Bone Marrow Transplantation (2010)

  8. No Access

    Article

    Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis

    Osteonecrosis is a frequent complication after treatment for childhood leukemia and other steroid-based therapies. The success rate of core decompression surgery is limited. Therefore, we evaluated relevant bi...

    I Müller, M Vaegler, C Holzwarth, N Tzaribatchev, S M Pfister, B Schütt in Leukemia (2008)

  9. No Access

    Article

    The MLL recombinome of acute leukemias

    Chromosomal rearrangements of the human MLL gene are a hallmark for aggressive (high-risk) pediatric, adult and therapy-associated acute leukemias. These patients need to be identified in order to subject these p...

    C Meyer, B Schneider, S Jakob, S Strehl, A Attarbaschi, S Schnittger, C Schoch in Leukemia (2006)

  10. No Access

    Article

    Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation

    Relapse is a major problem after allogeneic transplantation in children with acute B-lineage lymphoblastic leukemias (ALL) and lymphomas and additional therapeutic strategies are needed to increase graft versus l...

    M Pfeiffer, S Stanojevic, T Feuchtinger, J Greil in Bone Marrow Transplantation (2005)

  11. No Access

    Article

    Comment on ‘CD34+ selected hematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment of graft failure’ – G Milone et al

    P Lang, D Niethammer, P Bader, J Greil in Bone Marrow Transplantation (2005)

  12. No Access

    Article

    Telomeres and telomerase in paediatric patients with T-cell acute lymphoblastic leukaemia (T-ALL)

    E Kleideiter, U Bangerter, M Schwab, P Boukamp, E Koscielniak, U Klotz, J Greil in Leukemia (2005)

  13. No Access

    Article

    Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective

    Children with leukemias and increasing mixed chimerism (increasing MC) after allogeneic stem cell transplantation have the highest risk to relapse. Early immunological intervention was found to be effective in...

    P Bader, H Kreyenberg, W Hoelle, G Dueckers, B Kremens in Bone Marrow Transplantation (2004)

  14. No Access

    Article

    Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago

    P Lang, T Klingebiel, M Schumm, R Handgretinger, J Greil in Bone Marrow Transplantation (2004)

  15. Article

    Erratum: Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

    Correction to: Bone Marrow Transplantation (2004) 33, 189–195. doi:10.1038/sj.bmt.1704329; Published online: 8 December 2003. The author names and affiliations were published incorrectly; the correct version i...

    S Corbacioglu, J Greil, C Peters, N Wulffraat, H J Laws in Bone Marrow Transplantation (2004)

  16. No Access

    Article

    Transplantation of CD34+ enriched allografts in children with nonmalignant diseases: does graft manipulation necessarily result in high incidence of graft failure?

    P Lang, R Handgretinger, J Greil, P Bader, M Schumm in Bone Marrow Transplantation (2004)

  17. No Access

    Article

    Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

    Veno-occlusive disease (VOD) of the liver is a complication observed particularly in patients undergoing hematopoietic stem cell transplantation (HSCT). Defibrotide (DF) is a polydeoxyribonucleotide with aptam...

    S Corbacioglu, J Greil, C Peters, N Wulffraat, H J Laws in Bone Marrow Transplantation (2004)

  18. No Access

    Article

    Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases

    Transplantation of allogeneic stem cells is currently the only curative treatment for some nonmalignant pediatric diseases. We investigated whether transplantation of purified CD34+ stem cells prevents acute and ...

    P Lang, T Klingebiel, P Bader, J Greil, M Schumm in Bone Marrow Transplantation (2004)

  19. No Access

    Article

    Successful unrelated allogeneic stem cell transplantation after treatment of lymphoid blast crisis CML with imatinib and imatinib-containing conditioning regimen in a 16-year-old male

    M Koch, P Lang, P Bader, H Kreyenberg, M Schumm in Bone Marrow Transplantation (2003)

  20. No Access

    Article

    A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors

    Positively selected CD34+ hematopoietic stem cells from unrelated donors (UD-HSCT) have been successfully transplanted, but little is known about immune reconstitution in this setting. Here we report a prospectiv...

    M Eyrich, C Leiler, P Lang, K Schilbach, M Schumm, P Bader in Bone Marrow Transplantation (2003)

previous disabled Page of 2